Discovery DMPK: changing paradigms in the eighties, nineties and noughties
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460440902729405
Reference80 articles.
1. Utility of metabolic stability screening: comparison ofin vitroandin vivoclearance
2. Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations
3. On The Rate and Extent of Drug Delivery to the Brain
4. Predicting the Volume of Distribution of Drugs in Humans
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Structure-property Relationships of Clinically Approved Protease Inhibitors;Current Medicinal Chemistry;2024-04
2. One small step in time, one giant leap for DMPK kind – a CRO perspective of the evolving core discipline of drug development;Xenobiotica;2022-08-03
3. Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization;Journal of Medicinal Chemistry;2020-07-07
4. The Future of ADME in Drug Design and Development;Pharmacology for Chemists: Drug Discovery in Context;2017-10-31
5. Discovery of AZD0156: The First Potent and Selective Inhibitor of ATM Kinase for Clinical Evaluation;Comprehensive Medicinal Chemistry III;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3